ABBV vs SMCI: Which Is the Better Buy?

Side-by-side comparison of AbbVie Inc. and Super Micro Computer, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-18.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C High Quality
VS
Super Micro Computer, Inc. · Technology
$28.56
+435.6% upside to fair value
Grade B
QuantHub Verdict
SMCI has more upside to fair value (+435.6%). ABBV trades at a lower forward P/E (14.9x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric ABBV SMCI
Current Price $208.05 $28.56
Fair Value Estimate $217.50 $152.97
Upside to Fair Value +4.5% +435.6%
Market Cap $367.9B $17.1B
Forward P/E 14.9x 19.5x
EV / EBITDA 16.7x 15.0x
Price / Sales 6.1x 0.6x
Price / FCF 20.9x 38.9x
Revenue Growth YoY +8.6% +152.8%
Gross Margin 83.7% 8.0%
Operating Margin 34.7% 3.7%
Return on Equity -129.24% 13.3%
Dividend Yield 3.2% 0%
FCF Yield 4.78% 2.57%
Analyst Consensus Buy Hold
Investment Thesis
ABBV — AbbVie Inc.
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
SMCI — Super Micro Computer, Inc.
Super Micro Computer, Inc. is a technology company specializing in server and storage systems with a dominant focus on AI GPU platforms that now drive over 70% of its revenues. The company benefits from a founder-led management team with deep industry expertise and long tenure, and it has scaled rapidly with revenue growth exceeding 150% year-over-year. Despite this explosive growth, profitabilit…
Accumulation Zones
Metric ABBV SMCI
Zone Low $163.13 $114.73
Zone High $184.88 $130.02
In Buy Zone? No Yes
← ABBV Research    SMCI Research →    All Research